CompletedNot Applicable

Testing the Effectiveness of WW Clinic GLP1

United States180 participantsStarted 2024-01-18

Plain-language summary

The study objective is to evaluate the efficacy of the WeightWatchers (WW) GLP-1 behavioral program + WW Clinic (formerly known as Sequence medical weight management program) on weight loss and related outcomes. Participants will be invited to take part and answer surveys at 0, 12 and 24 weeks.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 years or older
✓. BMI of \>30 or BMI of \>27 with one or more weight related medically qualifying condition (hypertension, dyslipidemia, sleep apnea, cardiovascular disease)
✓. Access to a smartphone or tablet that runs iOS/iPadOS 15.0 or later, or Android 7.0 or later
✓. A prescription for Wegovy, Mounjaro, or Zepbound

Exclusion criteria

✕. Diabetes
✕. Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2
✕. History of pancreatitis within 180 days
✕. Previous surgical obesity treatment
✕. Use of other anti-obesity medication in last 90 days
✕. Use of GLP-1 within the last 180 days
✕. Lost weight \>11 lbs in the last 90 days
✕. Pregnant, breastfeeding, intends to become pregnant, of child-bearing potential and not using a highly effective contraceptive method

What they're measuring

Change in Weight in Pounds From Week 0 to Week 24

Timeframe: 0 to 24 weeks

Trial details

NCT IDNCT06034457

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-17

Results submitted2025-10-02

View on ClinicalTrials.gov More Weight Loss trials